Ravi Chandra Yada

Mr. Ravi Chandra Yada


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
NSNan Sethakorn
Nan Sethakorn
EHErika Héninger
Erika Héninger
Cristina Sanchez De DiegoCristina Sanchez De Diego
Cristina Sanchez De Diego
ADAdeline B. Ding
Adeline B. Ding
RYRavi Chandra Yada
Ravi Chandra Yada
JLJoshua M Lang
Joshua M Lang
Bone metastases represent a lethal condition that frequently occurs in solid tumors such as prostate, breast, lung, and renal cell carcinomas, and increase the risk of skeletal-related events (SREs) including pain, pathologic fractures, and spinal cord compression. This unique metastatic niche consists of a multicellular complex that cancer cells co-opt to engender bone remodeling, immune suppression, and stromal-mediated therapeutic resistance. This review comprehensively discusses clinical challenges of bone metastases, novel preclinical models of the bone and bone marrow microenviroment, and crucial signaling pathways active in bone homeostasis and metastatic niche. These studies establish the context to summarize the current state of investigational agents targeting BM, and approaches to improve BM-targeting therapies. Finally, we discuss opportunities to advance research in bone and bone marrow microenvironments by increasing complexity of humanized preclinical models and fostering interdisciplinary collaborations to translational research in this challenging metastatic niche.